Article Details
Retrieved on: 2022-06-29 15:55:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Covid-19 vaccine maker BioNTech SE plans to develop targeted antibiotics that could be used against superbugs, bacteria that are resistant to more ...
Article found on: news.bloomberglaw.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here